Charles Schwab Investment Management Inc. Sells 7,169 Shares of U.S. Physical Therapy, Inc. $USPH

Charles Schwab Investment Management Inc. lessened its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 134,498 shares of the company’s stock after selling 7,169 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.89% of U.S. Physical Therapy worth $9,732,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in USPH. Point72 Asia Singapore Pte. Ltd. bought a new position in U.S. Physical Therapy in the 4th quarter valued at $39,000. Fifth Third Bancorp boosted its stake in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock valued at $75,000 after purchasing an additional 265 shares during the period. Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $84,000. Aquatic Capital Management LLC grew its holdings in shares of U.S. Physical Therapy by 18.0% in the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after purchasing an additional 198 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its stake in U.S. Physical Therapy by 35.0% in the 1st quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company’s stock worth $140,000 after buying an additional 500 shares during the period.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $87.5170 on Monday. The company has a market cap of $1.33 billion, a PE ratio of 38.22, a P/E/G ratio of 4.47 and a beta of 1.45. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $101.19. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The business has a 50-day simple moving average of $78.26 and a two-hundred day simple moving average of $76.75.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.10. The company had revenue of $197.34 million during the quarter, compared to analysts’ expectations of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.73 EPS. As a group, equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Friday, August 22nd. U.S. Physical Therapy’s payout ratio is currently 78.60%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the company’s stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $78.01, for a total value of $31,204.00. Following the completion of the transaction, the director owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Graham D. Reeve sold 763 shares of the stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $84.97, for a total transaction of $64,832.11. Following the sale, the chief operating officer directly owned 21,483 shares in the company, valued at approximately $1,825,410.51. The trade was a 3.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,955 shares of company stock worth $251,170 over the last three months. 2.00% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on USPH shares. Wall Street Zen raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. Finally, Barrington Research boosted their price target on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a report on Friday, August 8th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $110.25.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.